assisTek COVID-19 Virus - Read here.
The eSource Company
Have Questions? Contact Us Now LinkedIn twitter


| Overview | Experience

assisTek has been paving the way for integrating technology and data collection in clinical trials for over 18 years. Our achievements have been marked with success in studies all over the globe.

40 Countries
46 Languages
6,500+ Patients
150+ Multi-national Phase I, II, & III clinical trials

Independent metrics inidicate that assisTek has a track record of high satisfaction from clinic sites and study coordinators. assisTek strives to build solutions that are highly regarded by the study team and the end-user (including patients, nurses, and investigators).



EASE OF USE: 93% of Study team members rate assisTek solutions as Extremely Easy to Use, and Easy to Use.

Ease of Use - ePro

PATIENT SATISFACTION: 96% of Study Coordinators state that they think the patient would rate their assisTek solution as Excellent, Very Good, and Good.

Patient Satisfaction - ePro

RECOMMEND IN ANOTHER STUDY: 92% of Study Coordinators would recommend using the assisTek solution in another study.

Recommendations - ePro

Improve Critical Study Objectives

  • Patient Compliance
  • Patient Engagement
  • Safety Management
  • Data Management

Learn more about improving key aspects of your study. More Information

eSource In Clinical Trials | Support FDA Guidance

According to the FDA guidance on source data in electronic form, eSource will help to eliminate unnecessary duplication of data, reduce the opportunity for transcription errors, promote the real-time entry of electronic source data during subject visits, ensure the accuracy and completeness of data, and more.

assisTek's TotalSource solutions capture these improvements to source data, and are customized to each individual protocol. More Information

Company Overview

assisTek successfully fuses new developments in mobile technology with creative software solutions to revolutionize the collection of data from patients and clinicians in clinical trials. We have proudly been helping clinical trial teams achieve success for over 18 years, in 40 countries with 46 languages. Our expertise can support studies in any phase.

More Information

Quick Contact: Comments/Questions